Provectus Biopharmaceuticals Inc (PVCT)
0.1948
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Provectus Biopharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2006 | -14.89M% |
September 30, 2006 | -787.1K% |
June 30, 2006 | -591.2K% |
March 31, 2006 | -335.3K% |
December 31, 2005 | -441.7K% |
September 30, 2005 | -636.4K% |
June 30, 2005 | -183.9K% |
March 31, 2005 | -40.60K% |
December 31, 2004 | -5.60K% |
September 30, 2004 | -94.22K% |
June 30, 2004 | -158.3K% |
March 31, 2004 | -6.98K% |
Date | Value |
---|---|
December 31, 2003 | |
September 30, 2003 | |
June 30, 2003 | |
March 31, 2003 | |
December 31, 2002 | |
September 30, 2002 | |
June 30, 2002 | -763.8% |
March 31, 2002 | |
December 31, 2001 | |
September 30, 2001 | |
June 30, 2001 | |
March 31, 2001 | -1.00M% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Insmed Inc | -222.3% |
NeuroMetrix Inc | -125.2% |
Intra-Cellular Therapies Inc | -21.73% |
Rhythm Pharmaceuticals Inc | -171.8% |
Amylyx Pharmaceuticals Inc | 4.36% |